Accumulating evidence points toward a very high prevalence of prolonged neurological
symptoms among coronavirus disease 2019 (COVID-19) survivors. To date, there are no …

Most COVID-19 patients recovered with low mortality; however, some patients experienced
long-term symptoms described as “long-COVID” or “Post-COVID syndrome”(PCS). Patients …

Long COVID, a condition characterized by symptom and/or sign persistence following an
acute COVID-19 episode, is associated with reduced physical performance and endothelial …

Objective To explore the lived experience of 'brain fog'—the wide variety of neurocognitive
symptoms that can follow COVID-19. Design and setting A UK-wide longitudinal qualitative …

At the beginning of the coronavirus disease (COVID-19) pandemic, global efforts focused on
containing the spread of the virus and avoiding contagion. Currently, it is evident that health …

Abstract In early March 2020, the World Health Organization (WHO) proclaimed the novel
COVID-19 as a global pandemic. The coronavirus went on to be a life-threatening infection …

Objective To develop a comprehensive post-acute sequelae of COVID-19 (PASC) symptom
lexicon (PASCLex) from clinical notes to support PASC symptom identification and research …

SARS-CoV-2 infection affects multiple organs owing to the ubiquitous distribution of its target
receptor ACE-2. 1 Increasing interest has been paid to the postacute phase of COVID-19 …

Infection of the CNS with the SARS-CoV-2 can occur via different routes and results in para-
or post-infectious manifestations with a variety of neurological symptoms. In patients with …

The SARS-CoV-2 pandemic has affected in the last two years a large number of subjects,
with a high cost in terms of morbidity and mortality. The scientific community made progress …